C-KIT EXPRESSION ENHANCES THE LEUKEMOGENIC POTENTIAL OF 32D CELLS

被引:16
作者
HU, QL
TREVISAN, M
XU, Y
DONG, WF
BERGER, SA
LYMAN, SD
MINDEN, MD
机构
[1] UNIV TORONTO, ONTARIO CANC INST, DEPT MED BIOPHYS & MED, TORONTO, ON M4X 1K9, CANADA
[2] UNIV TORONTO, WELLESLEY HOSP, RES INST, TORONTO, ON M4Y 1J3, CANADA
[3] IMMUNEX RES & DEV CORP, SEATTLE, WA 98101 USA
关键词
32D; KIT; KIT LIGAND; LEUKEMIA; AML;
D O I
10.1172/JCI117954
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The growth of human leukemic cells in culture and in vivo is dependent upon the presence of hematopoietic growth factors, Most populations of human leukemic acute myeloblastic leukemia (AML) cells express c-Kit on their surface and respond to Kit ligand (KL) in culture, To determine if this interaction was of potential significance in vivo we used a mouse model system, 32D cells, a murine IL-3-dependent myeloid cell Line, were rendered KL responsive by transfection of the murine c-Kit, After injection of 32D or 32D-Kit cells into syngeneic hosts, animals bearing 32D-Kit cells, but not 32D cells, became moribund and were killed, These animals had circulating leukemic blast cells, infiltration of bone marrow, spleen, brain, liver, lung, and kidney, Cells recovered from some of the animals continued to be dependent upon IL-3 or KL for growth while in other cases the cells were factor independent This model illustrates that the constitutive expression of c-Kit enhances the leukemic potential of 32D cells, The model will be useful for studying the progression of leukemia in vivo and testing whether interruption of the interaction of Kit and KL can affect the growth of leukemic cells.
引用
收藏
页码:2530 / 2538
页数:9
相关论文
共 60 条
[1]   EXPRESSION OF FUNCTIONAL C-KIT RECEPTORS RESCUES THE GENETIC-DEFECT OF W MUTANT MAST-CELLS [J].
ALEXANDER, WS ;
LYMAN, SD ;
WAGNER, EF .
EMBO JOURNAL, 1991, 10 (12) :3683-3691
[2]   MOLECULAR-CLONING OF MAST-CELL GROWTH-FACTOR, A HEMATOPOIETIN THAT IS ACTIVE IN BOTH MEMBRANE-BOUND AND SOLUBLE FORMS [J].
ANDERSON, DM ;
LYMAN, SD ;
BAIRD, A ;
WIGNALL, JM ;
EISENMAN, J ;
RAUCH, C ;
MARCH, CJ ;
BOSWELL, HS ;
GIMPEL, SD ;
COSMAN, D ;
WILLIAMS, DE .
CELL, 1990, 63 (01) :235-243
[3]  
ANDERSON DM, 1991, CELL GROWTH DIFFER, V2, P373
[4]   INTERLEUKIN-6 PRODUCTION BY THE BLAST CELLS OF ACUTE MYELOBLASTIC-LEUKEMIA - REGULATION BY ENDOGENOUS INTERLEUKIN-1 AND BIOLOGICAL IMPLICATIONS [J].
BEAUCHEMIN, V ;
VILLENEUVE, L ;
RODRIGUEZCIMADEVILLA, JC ;
RAJOTTE, D ;
KENNEY, JS ;
CLARK, SC ;
HOANG, T .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 148 (03) :353-361
[5]  
BERNSTEIN A, 1990, CIBA F SYMP, V148, P158
[6]  
BRADBURY D, 1990, LEUKEMIA, V4, P44
[7]  
BROUDY VC, 1992, BLOOD, V80, P60
[8]  
BROUDY VC, 1992, BLOOD, V79, P338
[9]   A HUMAN LYMPHOMA CELL-LINE WITH MULTIPLE IMMUNOGLOBULIN REARRANGEMENTS [J].
CHANG, H ;
MESSNER, HA ;
WANG, XH ;
YEE, C ;
ADDY, L ;
MEHARCHAND, J ;
MINDEN, MD .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) :1014-1020
[10]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299